# Iradimed Corp (IRMD) > Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/iradimed-corp/ JSON: https://steadybase.io/company/iradimed-corp.json Checked Nov 10, 2026. Latest filing read: Oct 30, 2026. ## Company - Legal name: IRADIMED CORP - Ticker: IRMD (Nasdaq) - SEC CIK: 0001325618 - Industry: Surgical & Medical Instruments & Apparatus (SIC 3841) - Headquarters: Orlando, FL - Fiscal year ends: December 31 - SEC filer category: Non-accelerated filer
Smaller reporting company - Website: iradimed.com - LinkedIn: https://www.linkedin.com/company/iradimed - Next earnings date: Jan 29, 2027 (estimated from past 8-K timing) ## Key facts - Revenue: $83.8M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 6, 2026). Source: https://www.sec.gov/Archives/edgar/data/1325618/000110465926024691/0001104659-26-024691-index.html - Operating income: $26.1M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 6, 2026). Source: https://www.sec.gov/Archives/edgar/data/1325618/000110465926024691/0001104659-26-024691-index.html - Net income: $22.5M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 6, 2026). Source: https://www.sec.gov/Archives/edgar/data/1325618/000110465926024691/0001104659-26-024691-index.html - SG&A: $35.2M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 6, 2026). Source: https://www.sec.gov/Archives/edgar/data/1325618/000110465926024691/0001104659-26-024691-index.html - Employees: 166 as of Dec 31, 2025, as reported in an SEC filing. Source: https://www.sec.gov/Archives/edgar/data/1325618/000110465926024691/irmd-20251231x10k.htm - Shares outstanding: 12,788,153 as of Oct 30, 2026 (10-Q filed Oct 30, 2026). Source: https://www.sec.gov/Archives/edgar/data/1325618/000162828026068576/0001628280-26-068576-index.html - Auditor: Rsm Us LLP, Orlando, Florida, named in the latest 10-K. Source: https://www.sec.gov/Archives/edgar/data/1325618/000110465926024691/irmd-20251231x10k.htm ## Business IRADIMED CORPORATION (“IRadimed”, the “Company,” “we,” “us,” “our” or similar terms) develops, manufactures, markets and distributes Magnetic Resonance Imaging (“MRI”) compatible medical devices and related accessories, disposables and services relating to them. We were originally incorporated in Oklahoma under the name IRI Development, Inc. in 1992, and we merged our Oklahoma corporation into the newly formed Delaware corporation, IRADIMED CORPORATION, in April 2014. Source: Item 1. Business, https://www.sec.gov/Archives/edgar/data/1325618/000110465926024691/irmd-20251231x10k.htm ## Annual results | Fiscal year ended | Revenue | Operating income | Net income | SG&A | |---|---|---|---|---| | Dec 31, 2025 | $83.8M | $26.1M | $22.5M | $35.2M | | Dec 31, 2024 | $73.2M | $22.0M | $19.2M | $31.6M | | Dec 31, 2023 | $65.6M | $20.0M | $17.2M | $27.3M | | Dec 31, 2022 | $53.3M | $15.6M | $12.8M | $23.4M | | Dec 31, 2021 | $41.8M | $9.8M | $9.3M | $20.3M | Each figure comes from the annual report for that year. Filing links for every figure: https://steadybase.io/company/iradimed-corp.json ## Officers and directors - John Glenn, CFO. Source: Form 4 filed Jun 23, 2026, https://www.sec.gov/Archives/edgar/data/1325618/000125349726000005/0001253497-26-000005-index.htm - Roger E. Susi, CEO, President, Chairman. LinkedIn: https://linkedin.com/in/roger-susi-b2b6963. Source: Form 4 filed Jun 2, 2026, https://www.sec.gov/Archives/edgar/data/1325618/000161380126000043/0001613801-26-000043-index.htm - Jeff Chiprin, Chief Commercial Officer. Source: Form 4 filed Mar 5, 2026, https://www.sec.gov/Archives/edgar/data/1325618/000204748926000002/0002047489-26-000002-index.htm - Hilda Scharen-Guivel, Board member (per proxy). Source: DEF 14A filed Apr 30, 2026, https://www.sec.gov/Archives/edgar/data/1325618/000162828026028903/irmd-20260430.htm - James Hawkins, Board member (per proxy). Source: DEF 14A filed Apr 30, 2026, https://www.sec.gov/Archives/edgar/data/1325618/000162828026028903/irmd-20260430.htm - Joe Kiani, Board member (per proxy). Source: DEF 14A filed Apr 30, 2026, https://www.sec.gov/Archives/edgar/data/1325618/000162828026028903/irmd-20260430.htm - Monty Allen, Board member (per proxy). Source: DEF 14A filed Apr 30, 2026, https://www.sec.gov/Archives/edgar/data/1325618/000162828026028903/irmd-20260430.htm - Roger Susi, Board member (per proxy). Source: DEF 14A filed Apr 30, 2026, https://www.sec.gov/Archives/edgar/data/1325618/000162828026028903/irmd-20260430.htm ## Recent 8-K events - Oct 30, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1325618/000162828026068454/irmd-20261030.htm - Jul 31, 2026: Item 8.01, Other events. Source: https://www.sec.gov/Archives/edgar/data/1325618/000162828026051240/irmd-20260731.htm - Jun 24, 2026: Item 5.07, Submission of matters to a vote of security holders. Source: https://www.sec.gov/Archives/edgar/data/1325618/000162828026045059/irmd-20260624.htm - May 1, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1325618/000162828026029125/irmd-20260501.htm - Feb 10, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1325618/000110465926012356/irmd-20260210x8k.htm - Dec 8, 2025: Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1325618/000110465925119090/irmd-20251205x8k.htm - Nov 3, 2025: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1325618/000110465925105298/irmd-20251103x8k.htm - Sep 2, 2025: Item 5.02, Departure or appointment of directors or officers; compensation; Item 7.01, Regulation FD disclosure; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1325618/000155837025011834/irmd-20250827x8k.htm - Aug 1, 2025: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1325618/000155837025009933/irmd-20250801x8k.htm - Jun 23, 2025: Item 5.07, Submission of matters to a vote of security holders. Source: https://www.sec.gov/Archives/edgar/data/1325618/000155837025008791/irmd-20250623x8k.htm ## Insider trades (Form 4) - Sep 3, 2026: Monty K. Allen (Director) sold 1,419 shares, about $122,622. Source: https://www.sec.gov/Archives/edgar/data/1325618/000125335226000010/0001253352-26-000010-index.htm - Jun 4, 2026: Hilda Frederique Scharen-Guivel (Director) sold 3,000 shares, about $285,000. Source: https://www.sec.gov/Archives/edgar/data/1325618/000195012926000006/0001950129-26-000006-index.htm - Jun 1, 2026: Roger E. Susi (CEO, President, Chairman) sold 2,500 shares, about $226,507. Source: https://www.sec.gov/Archives/edgar/data/1325618/000161380126000043/0001613801-26-000043-index.htm - May 27, 2026: Roger E. Susi (CEO, President, Chairman) sold 7,500 shares, about $691,044. Source: https://www.sec.gov/Archives/edgar/data/1325618/000161380126000041/0001613801-26-000041-index.htm - May 19, 2026: Roger E. Susi (CEO, President, Chairman) sold 7,500 shares, about $657,265. Source: https://www.sec.gov/Archives/edgar/data/1325618/000161380126000038/0001613801-26-000038-index.htm - May 12, 2026: Roger E. Susi (CEO, President, Chairman) sold 7,500 shares, about $631,341. Source: https://www.sec.gov/Archives/edgar/data/1325618/000161380126000034/0001613801-26-000034-index.htm - May 5, 2026: Roger E. Susi (CEO, President, Chairman) sold 7,500 shares, about $642,862. Source: https://www.sec.gov/Archives/edgar/data/1325618/000161380126000030/0001613801-26-000030-index.htm - Apr 28, 2026: Roger E. Susi (CEO, President, Chairman) sold 7,500 shares, about $657,709. Source: https://www.sec.gov/Archives/edgar/data/1325618/000161380126000028/0001613801-26-000028-index.htm - Apr 21, 2026: Roger E. Susi (CEO, President, Chairman) sold 7,500 shares, about $694,124. Source: https://www.sec.gov/Archives/edgar/data/1325618/000161380126000026/0001613801-26-000026-index.htm - Apr 14, 2026: Roger E. Susi (CEO, President, Chairman) sold 7,500 shares, about $697,189. Source: https://www.sec.gov/Archives/edgar/data/1325618/000161380126000024/0001613801-26-000024-index.htm - Apr 7, 2026: Roger E. Susi (CEO, President, Chairman) sold 7,500 shares, about $717,208. Source: https://www.sec.gov/Archives/edgar/data/1325618/000161380126000022/0001613801-26-000022-index.htm - Mar 30, 2026: Roger E. Susi (CEO, President, Chairman) sold 7,500 shares, about $712,614. Source: https://www.sec.gov/Archives/edgar/data/1325618/000161380126000020/0001613801-26-000020-index.htm - Mar 24, 2026: Roger E. Susi (CEO, PRESIDENT, CHAIRMAN) sold 7,500 shares, about $752,609. Source: https://www.sec.gov/Archives/edgar/data/1325618/000161380126000018/0001613801-26-000018-index.htm - Mar 17, 2026: Roger E. Susi (CEO, PRESIDENT, CHAIRMAN) sold 7,500 shares, about $762,971. Source: https://www.sec.gov/Archives/edgar/data/1325618/000161380126000016/0001613801-26-000016-index.htm - Mar 10, 2026: Roger E. Susi (CEO, PRESIDENT, CHAIRMAN) sold 7,500 shares, about $750,475. Source: https://www.sec.gov/Archives/edgar/data/1325618/000161380126000014/0001613801-26-000014-index.htm ## Latest filings - 8-K filed Oct 30, 2026: https://www.sec.gov/Archives/edgar/data/1325618/000162828026068454/irmd-20261030.htm - 10-K filed Mar 6, 2026: https://www.sec.gov/Archives/edgar/data/1325618/000110465926024691/irmd-20251231x10k.htm - 10-Q filed Oct 30, 2026: https://www.sec.gov/Archives/edgar/data/1325618/000162828026068576/irmd-20260930.htm - DEF 14A filed Apr 30, 2026: https://www.sec.gov/Archives/edgar/data/1325618/000162828026028903/irmd-20260430.htm ## About this data SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from. Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/